Milestone Pharmaceuticals Inc. SEC filings MIST
Milestone Pharmaceuticals Inc. has 421 filings in SEC EDGAR's recent list, going back to Jul 30, 2007. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (listing notice). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Listing notice
|
Oct 28, 2026 | Oct 23, 2026 |
| 8-K |
Current report
Other events
|
Sep 3, 2026 | Sep 3, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2026 | Aug 12, 2026 |
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 15, 2026 | Jun 10, 2026 |
| EFFECT | Filing | May 22, 2026 | — |
| CORRESP | Letter to the SEC | May 20, 2026 | — |
| UPLOAD | Letter from the SEC | May 18, 2026 | — |
| S-3 | Shelf registration | May 13, 2026 | — |
| 8-K |
Current report
Results of operations
|
May 13, 2026 | May 13, 2026 |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| ARS | Annual report to shareholders | Apr 30, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 30, 2026 | — |
| DEF 14A | Proxy statement | Apr 30, 2026 | Jun 10, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 20, 2026 | Mar 20, 2026 |
| 10-K | Annual report | Mar 20, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Other events
|
Jan 26, 2026 | Jan 26, 2026 |
| 8-K |
Current report
Other events
|
Jan 13, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Other events
|
Jan 6, 2026 | Jan 6, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 15, 2025 | Dec 12, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2025 | Nov 12, 2025 |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| S-8 | Employee stock plan registration | Aug 12, 2025 | — |
| 8-K |
Current report
Results of operations
|
Aug 12, 2025 | Aug 12, 2025 |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Jul 14, 2025 | Jul 11, 2025 |
| 424B5 | Prospectus supplement | Jul 14, 2025 | — |
| 424B5 | Prospectus supplement | Jul 11, 2025 | — |
| 8-K |
Current report
Material agreement, Other events
|
Jul 11, 2025 | Jul 10, 2025 |
| 8-K |
Current report
Other events
|
Jun 16, 2025 | Jun 16, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 12, 2025 | Jun 10, 2025 |
| 8-K |
Current report
Results of operations
|
May 14, 2025 | May 14, 2025 |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| ARS | Annual report to shareholders | Apr 30, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 30, 2025 | — |
| DEF 14A | Proxy statement | Apr 30, 2025 | Jun 10, 2025 |
| 8-K |
Current report
Other events
|
Mar 28, 2025 | Mar 28, 2025 |
| 8-K | Current report | Mar 19, 2025 | Mar 18, 2025 |
| 424B5 | Prospectus supplement | Mar 18, 2025 | — |
| 8-K |
Current report
Material agreement, Other events
|
Mar 18, 2025 | Mar 18, 2025 |
| S-8 | Employee stock plan registration | Mar 13, 2025 | — |
| 8-K |
Current report
Results of operations
|
Mar 13, 2025 | Mar 13, 2025 |
| 10-K | Annual report | Mar 13, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 25, 2025 | Feb 25, 2025 |
| EFFECT | Filing | Nov 22, 2024 | — |
| CORRESP | Letter to the SEC | Nov 20, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 19, 2024 | — |
| S-3 | Shelf registration | Nov 12, 2024 | — |
| S-8 | Employee stock plan registration | Nov 12, 2024 | — |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Regulation FD disclosure
|
Sep 4, 2024 | Aug 28, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| ARS | Annual report to shareholders | Jul 15, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Jul 15, 2024 | — |
| DEFA14A | Additional proxy material | Jul 15, 2024 | — |
| DEF 14A | Proxy statement | Jul 15, 2024 | Aug 28, 2024 |
| 8-K |
Current report
Material agreement, Officer or director change, Other events
|
Jul 15, 2024 | Jul 14, 2024 |
| 8-K |
Current report
Other events
|
May 29, 2024 | May 29, 2024 |
| 8-K |
Current report
Results of operations
|
May 13, 2024 | May 13, 2024 |
| 10-Q | Quarterly report | May 13, 2024 | Mar 31, 2024 |
| 10-K/A | Amended annual report | Apr 29, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Other events
|
Apr 8, 2024 | Apr 8, 2024 |
| 8-K |
Current report
Other events
|
Mar 28, 2024 | Mar 28, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 21, 2024 | Mar 21, 2024 |
| 10-K | Annual report | Mar 21, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
Mar 4, 2024 | Feb 28, 2024 |
| 424B5 | Prospectus supplement | Mar 1, 2024 | — |
| 424B5 | Prospectus supplement | Feb 28, 2024 | — |
| 8-K |
Current report
Other events
|
Feb 26, 2024 | Feb 26, 2024 |
| 8-K |
Current report
Other events
|
Dec 26, 2023 | Dec 26, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2023 | Nov 13, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 13, 2023 | Nov 11, 2023 |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 7, 2023 | Nov 7, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 24, 2023 | Oct 24, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2023 | Aug 10, 2023 |
| 10-Q | Quarterly report | Aug 10, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Jun 9, 2023 | Jun 7, 2023 |
| 424B5 | Prospectus supplement | May 31, 2023 | — |
| 10-K/A | Amended annual report | May 31, 2023 | Dec 31, 2022 |
| EFFECT | Filing | May 26, 2023 | — |
| CORRESP | Letter to the SEC | May 24, 2023 | — |
| UPLOAD | Letter from the SEC | May 18, 2023 | — |
| S-3 | Shelf registration | May 15, 2023 | — |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 11, 2023 |
| 10-Q | Quarterly report | May 11, 2023 | Mar 31, 2023 |
| S-8 | Employee stock plan registration | Apr 28, 2023 | — |
| ARS | Annual report to shareholders | Apr 28, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 28, 2023 | — |
| DEF 14A | Proxy statement | Apr 28, 2023 | Jun 7, 2023 |
| 8-K |
Current report
New debt, Unregistered share sale, Regulation FD disclosure
|
Mar 31, 2023 | Mar 27, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 29, 2023 | Mar 29, 2023 |
| 10-K | Annual report | Mar 29, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Mar 28, 2023 | Mar 27, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change
|
Mar 27, 2023 | Mar 21, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 10, 2023 | Mar 10, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 7, 2023 | Mar 7, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 6, 2022 | Dec 6, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2022 | Nov 10, 2022 |
| 10-Q | Quarterly report | Nov 10, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 17, 2022 | Oct 17, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2022 | Aug 10, 2022 |
| 10-Q | Quarterly report | Aug 10, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jul 8, 2022 | Jul 8, 2022 |
| 10-Q | Quarterly report | May 12, 2022 | Mar 31, 2022 |
| DEFA14A | Additional proxy material | May 2, 2022 | — |
| DEF 14A | Proxy statement | May 2, 2022 | Jul 5, 2022 |
| PRE 14A | Preliminary proxy statement | Apr 22, 2022 | Jun 23, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 24, 2022 | Mar 24, 2022 |
| S-8 | Employee stock plan registration | Mar 24, 2022 | — |
| 10-K | Annual report | Mar 24, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Unregistered share sale, Officer or director change
|
Feb 16, 2022 | Feb 15, 2022 |
| EFFECT | Filing | Feb 2, 2022 | — |
| CORRESP | Letter to the SEC | Jan 31, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 19, 2021 | — |
| S-3 | Shelf registration | Nov 12, 2021 | — |
| 8-K |
Current report
Results of operations, Other events
|
Nov 12, 2021 | Nov 12, 2021 |
| 10-Q | Quarterly report | Nov 12, 2021 | Sep 30, 2021 |
| EFFECT | Filing | Nov 5, 2021 | — |
| CORRESP | Letter to the SEC | Nov 4, 2021 | — |
| S-3/A | Filing | Oct 28, 2021 | — |
| CORRESP | Letter to the SEC | Oct 5, 2021 | — |
| CORRESP | Letter to the SEC | Oct 1, 2021 | — |
| 10-Q | Quarterly report | Aug 11, 2021 | Jun 30, 2021 |
| UPLOAD | Letter from the SEC | Jul 6, 2021 | — |
| S-3 | Shelf registration | Jun 25, 2021 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 21, 2021 | Jun 14, 2021 |
| 8-K |
Current report
Other events
|
Jun 2, 2021 | Jun 2, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
May 17, 2021 | May 15, 2021 |
| 10-Q | Quarterly report | May 17, 2021 | Mar 31, 2021 |
| DEFA14A | Additional proxy material | Apr 30, 2021 | — |
| DEF 14A | Proxy statement | Apr 30, 2021 | Apr 30, 2021 |
| 8-K |
Current report
Results of operations, Other events
|
Mar 30, 2021 | Mar 29, 2021 |
| S-8 | Employee stock plan registration | Mar 29, 2021 | — |
| 10-K | Annual report | Mar 29, 2021 | Dec 31, 2020 |
| EFFECT | Filing | Dec 18, 2020 | — |
| CORRESP | Letter to the SEC | Dec 16, 2020 | — |
| 10-Q | Quarterly report | Nov 13, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Material agreement, Other events
|
Oct 26, 2020 | Oct 22, 2020 |
| 424B5 | Prospectus supplement | Oct 26, 2020 | — |
| 10-K/A | Amended annual report | Oct 23, 2020 | Dec 31, 2019 |
| S-3MEF | Form s-3mef | Oct 22, 2020 | — |
| 424B5 | Prospectus supplement | Oct 22, 2020 | — |
| 8-K |
Current report
Officer or director change
|
Sep 22, 2020 | Sep 21, 2020 |
| UPLOAD | Letter from the SEC | Aug 27, 2020 | — |
| S-3 | Shelf registration | Aug 20, 2020 | — |
| 10-Q | Quarterly report | Aug 12, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Material agreement
|
Jul 29, 2020 | Jul 29, 2020 |
| 424B5 | Prospectus supplement | Jul 29, 2020 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jul 23, 2020 | Jul 22, 2020 |
| EFFECT | Filing | Jul 6, 2020 | — |
| CORRESP | Letter to the SEC | Jul 1, 2020 | — |
| UPLOAD | Letter from the SEC | Jun 25, 2020 | — |
| S-3 | Shelf registration | Jun 19, 2020 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 9, 2020 | Jun 4, 2020 |
| 10-Q | Quarterly report | May 14, 2020 | Mar 31, 2020 |
| DEFA14A | Additional proxy material | May 5, 2020 | — |
| DEF 14A | Proxy statement | May 5, 2020 | Jun 5, 2020 |
| 8-K |
Current report
Other events
|
Mar 23, 2020 | Mar 23, 2020 |
| S-8 | Employee stock plan registration | Mar 6, 2020 | — |
| 10-K | Annual report | Mar 6, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Other events
|
Dec 17, 2019 | Dec 17, 2019 |
| 8-K |
Current report
Officer or director change
|
Dec 3, 2019 | Nov 29, 2019 |
| 10-Q | Quarterly report | Nov 13, 2019 | Sep 30, 2019 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Nov 13, 2019 | Nov 11, 2019 |
| 8-K |
Current report
Officer or director change
|
Oct 15, 2019 | Oct 8, 2019 |
| 8-K |
Current report
Officer or director change
|
Sep 20, 2019 | Sep 18, 2019 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 10, 2019 | Sep 9, 2019 |
| 10-Q | Quarterly report | Aug 13, 2019 | Jun 30, 2019 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2019 | Aug 13, 2019 |
| 10-Q | Quarterly report | Jun 19, 2019 | Mar 31, 2019 |
| 8-K |
Current report
Results of operations
|
May 24, 2019 | May 24, 2019 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
May 15, 2019 | May 13, 2019 |
| S-8 | Employee stock plan registration | May 9, 2019 | — |
| 424B4 | Prospectus | May 9, 2019 | — |
| EFFECT | Filing | May 8, 2019 | — |
| S-1MEF | Filing | May 8, 2019 | — |
| CERT | Filing | May 7, 2019 | — |
| CORRESP | Letter to the SEC | May 6, 2019 | — |
| CORRESP | Letter to the SEC | May 6, 2019 | — |
| 8-A12B | Filing | May 6, 2019 | — |
| S-1/A | Amended registration statement | Apr 29, 2019 | — |
| CORRESP | Letter to the SEC | Apr 19, 2019 | — |
| CORRESP | Letter to the SEC | Apr 12, 2019 | — |
| S-1 | Registration statement | Apr 12, 2019 | — |
| UPLOAD | Letter from the SEC | Mar 21, 2019 | — |
| DRSLTR | Filing | Mar 15, 2019 | — |
| DRS/A | Filing | Mar 15, 2019 | — |
| UPLOAD | Letter from the SEC | Mar 7, 2019 | — |
| DRS/A | Filing | Feb 28, 2019 | — |
| DRSLTR | Filing | Feb 27, 2019 | — |
| UPLOAD | Letter from the SEC | Feb 11, 2019 | — |
| DRS | Filing | Dec 21, 2018 | — |
| D | Filing | Oct 26, 2018 | — |
| D | Filing | Jul 25, 2017 | — |
| D | Filing | Jun 15, 2015 | — |
| D | Filing | Jun 14, 2011 | — |
| REGDEX | Auto-generated paper document | Jul 30, 2007 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MIST (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Quebec, Canada
- Headquarters
- Montreal, Quebec, Canada
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1408443
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.